http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e116602a21fb1e295a3746d5348e2e2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Berneman N. Berneman |
| name | Zwi N Berneman Zwi N. Berneman |
| given-name | Zwi N Zwi Zwi N. |
| organization-name | Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, 2650 Edegem, Belgium *Laboratory of Experimental Hematology, University of Antwerp, Antwerp University Hospital, Edegem, Belgium; Laboratory of Experimental Hematology, University of Antwerp Antwerp Belgium; Vaccine and Infectious Disease Institute, University of Antwerp Antwerp Belgium; Centre for Cellular Therapy and Regenerative Medicine, Antwerp University Hospital Antwerp Belgium Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), Faculty of Medicine, University of Antwerp Antwerp Belgium Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital, Edegem, Belgium a Vaccine & Infectious Disease Institute (VIDI), Laboratory of Experimental Hematology, Faculty of Medicine, University of Antwerp, Antwerp, Belgium; b Center for Cellular Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Belgium Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital (UZA), 2650 Edegem, Belgium Laboratory of Experimental Hematology, Faculty of Medicin, Antwerp University , Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital , Belgium Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium From the Laboratory of Experimental Hematology, Antwerp University Hospital, University of Antwerp; the Laboratory of Molecular Genetics, Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Antwerp; and the Laboratory of Cancer Research and Clinical Oncology, University of Antwerp, Antwerp, Belgium. Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital (UZA), Edegem, Belgium UNIVERSITY OF ANTWERP Department of Haematology Antwerp University Hospital Edegem Belgium Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Centre for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium Antwerp University Hospital, Antwerp, Belgium;; Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, B-2610 Wilrijk (Antwerp), Belgium.; Center for Cell Therapy and Regenerative Medicine (CCTRM), Antwerp University Hospital, B-2650 Edegem (Antwerp), Belgium. University of Antwerp, Faculty of Medicine, Vaccine and Infectious Disease Institute (Vaxinfectio) and Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp B-2650, Belgium; Laboratory of Experimental Hematology1 and Department of Haematology, Antwerp University Hospital, Edegem, Belgium; Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium Laboratory of Experimental Hematology, Faculty of Medicine, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium. Department of Hematology, Antwerp University Hospital Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, 2610 Antwerp, Belgium Laboratory of Experimental Hematology, University of Antwerp, Wilrijk, Antwerp, Belgium; Department of Hematology, Antwerp University Hospital, Edegem, Antwerp, Belgium a Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VaxInfectio), Faculty of Medicine, University of Antwerp, Antwerp, Belgium;; b Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium 1Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk, Belgium Laboratory of Experimental Hematology, Tumor Immunology Group (TIGR), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium a Vaccine & Infectious Disease Institute (Vaxinfectio), Laboratory of Experimental Hematology (LEH), Tumor Immunology Group (TIGR), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium;; b Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium; Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium From the Laboratory of Experimental Hematology and the Department of Cardiac Surgery, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium; the Departments of Hematology and Clinical Chemistry, Microbiology and Immunology, University of Ghent, Ghent University Hospital, Ghent, Belgium; and the Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, NY. Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Antwerp University Hospital, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk, Belgium Department of Haematology, Antwerp University Hospital, Edegem, Belgium; Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium |
Incoming Links
Total number of triples: 164.